Vaijayanti (Holarrhena antidysenterica)

Holarrhena antidysenterica is an Ayurvedic medicinal tree whose bark contains alkaloids like conessine that demonstrate calcium channel blocking activity. The bark preparations have been traditionally used for gastrointestinal disorders, particularly diarrhea and dysentery.

Origin & History

Holarrhena antidysenterica (Vaijayanti) is a tropical shrub from the Apocynaceae family native to India and South Asia, with therapeutic compounds primarily extracted from its stem bark. The bark contains 1.5-3% steroidal alkaloids by weight, with conessine as the principal alkaloid at yields up to 0.4%.

Historical & Cultural Context

Known as Tewāj, Amkudu (Telugu), Erukkalaipalai (Tamil), or Conesse/Tellicherry bark in English, this plant has been used across South Asian traditional medicine systems. Historical applications focused on treating dysentery, parasitic worm infections, and various gastrointestinal conditions.

Health Benefits

• Gastrointestinal support through calcium channel blocking and histamine receptor activation (mechanism studies only)
• Traditional antidiarrheal effects from bark preparations (ethnopharmacological documentation)
• Potential antidiabetic properties from seed extracts (traditional use only)
• Antiparasitic/anthelmintic activity against intestinal worms (traditional application)
• Possible inflammatory bowel disease support including colitis and Crohn's disease (traditional use basis)

How It Works

The primary alkaloid conessine blocks L-type calcium channels and modulates histamine H3 receptors, affecting smooth muscle contraction in the gastrointestinal tract. These mechanisms may contribute to antispasmodic effects and reduced intestinal motility. The bark also contains other steroidal alkaloids that may influence cholinergic pathways.

Scientific Research

The available research consists primarily of phytochemical characterization studies and ethnopharmacological reviews rather than clinical trials. No human clinical trials, randomized controlled trials, or meta-analyses with specific PMIDs were found in the research dossier.

Clinical Summary

Current evidence is limited to mechanism studies and ethnopharmacological documentation rather than controlled human trials. Laboratory studies have confirmed calcium channel blocking activity of isolated alkaloids, but therapeutic efficacy in humans remains unproven. Traditional use documentation supports antidiarrheal applications, though standardized clinical data is lacking. Most research focuses on compound identification rather than clinical outcomes.

Nutritional Profile

Holarrhena antidysenterica (Vaijayanti) is a medicinal plant, not a dietary staple, so conventional macronutrient profiling is limited; however, bioactive compound characterization is reasonably documented. Primary bioactive constituents are steroidal alkaloids concentrated in bark and seeds: conessine (major alkaloid, ~1.5–3.2% dry weight in bark), kurchicine, holarrhimine, holarrhesine, conarrhimine, and holarrhine. Seeds contain approximately 20–25% fixed oils (fatty acid profile includes oleic, linoleic, and palmitic acids). Bark contains tannins (~8–12% dry weight) contributing to astringent antidiarrheal properties. Flavonoids including quercetin and kaempferol derivatives are present at trace levels (~0.1–0.4% dry weight). Phytosterols (beta-sitosterol, stigmasterol) detected in leaf and bark fractions. Crude fiber content in bark preparations is approximately 15–18% dry weight. Protein content in seeds estimated at 12–18% dry weight with limited bioavailability data. Saponins present at ~2–4% in root bark. Mineral content includes calcium (~180–220 mg/100g dry bark), potassium (~310 mg/100g), magnesium (~85 mg/100g), and iron (~12–15 mg/100g), though these values are derived from proximate analyses of dried bark powder. Vitamin content is not well characterized; trace amounts of tocopherols reported in seed oil fractions. Bioavailability of alkaloids such as conessine is moderate via oral route; tannins may reduce mineral absorption when consumed in therapeutic bark decoctions. Preparations are typically used at low doses (3–6g bark powder or 50–100mL decoction), so macronutrient contribution to diet is negligible.

Preparation & Dosage

No clinically studied dosage ranges are available in the current research. Traditional preparations use bark, leaves, or seeds, but standardization parameters and recommended doses have not been established through clinical trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Triphala, Kutaja, Bilva, Musta, Chitrak

Safety & Interactions

Safety data is insufficient for modern supplement use, with traditional preparations potentially containing variable alkaloid concentrations. The calcium channel blocking activity may interact with cardiovascular medications or calcium channel blockers. Alkaloid-containing preparations should be avoided during pregnancy and breastfeeding due to unknown teratogenic potential. Gastrointestinal side effects or alkaloid toxicity could occur with excessive use.